{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:32:01Z","timestamp":1791513121329,"version":"4.3.4"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec id=\"ab-ebr240006-4\"><jats:title>Importance<\/jats:title><jats:p>Previous studies have identified familial exudative vitreoretinonpathy (FEVR) in patients with CTNNB1 syndrome based on severe congenital ocular phenotypes. However, ophthalmoscopy may not be sufficient to detect vision-threatening vitreoretinopathy in all patients.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr240006-5\"><jats:title>Objective<\/jats:title><jats:p>To report a consecutive retrospective case series of 11 patients with <jats:italic>CTNNB1<\/jats:italic> variants who had previously unremarkable ophthalmoscopic examination results and to describe their detailed ophthalmic phenotypes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr240006-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective case series was conducted at the Children\u2019s Hospital of Philadelphia from October 2022 to November 2023 among patients with identified variants in <jats:italic>CTNNB1<\/jats:italic> and previously documented normal results in office retinal examinations. These consecutive patients subsequently underwent an examination under anesthesia with fluorescein angiography. Detailed genotype information was analyzed for all patients, and each variant was mapped on the <jats:italic>CTNNB1<\/jats:italic> gene to observe any associations with severity of vitreoretinopathy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr240006-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Number of patients with vitreoretinopathy and number requiring treatment for vitreoretinopathy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr240006-8\"><jats:title>Results<\/jats:title><jats:p>The mean (SD) age at the time of CTNNB1 syndrome diagnosis was 2 (1) years, and the mean (SD) age at examination was 6 (3) years for the 11 total patients. A total of 9 patients had a diagnosis of strabismus, and 5 patients had undergone strabismus surgery. FEVR was present in 5 of 11 patients and in 9 eyes. The presence of disease requiring treatment was identified in 6 eyes, including 1 retinal detachment. Detailed genotype analysis of the patients found no clearly delineated high-risk loci in <jats:italic>CTNNB1<\/jats:italic> in association with high severity of FEVR.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr240006-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this case series study, nearly all patients with CTNNB1 syndrome required ophthalmic care for refractive error and strabismus, and a subset also required treatment for FEVR. These findings support consideration of ultra-widefield fluorescein angiography among individuals with CTNNB1 syndrome when feasible, including the use of sedation if such an assessment is not possible in the office setting.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.2847","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:01:30Z","timestamp":1723734090000},"page":"874","source":"Crossref","is-referenced-by-count":5,"title":["Vitreoretinopathy in Asymptomatic Children With CTNNB1 Syndrome"],"prefix":"10.1001","volume":"142","author":[{"given":"Emma C.","family":"Bedoukian","sequence":"first","affiliation":[{"name":"Roberts Individualized Medical Genetics Center, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Ophthalmology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Forbes","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Scoles","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ebr240006r1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.preteyeres.2018.11.008","article-title":"Wnt signaling in vascular eye diseases.","volume":"70","author":"Wang","year":"2019","journal-title":"Prog Retinal Eye Res"},{"issue":"11","key":"ebr240006r2","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.gim.2022.08.006","article-title":"Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.","volume":"24","author":"Kayumi","year":"2022","journal-title":"Genetics Med"},{"issue":"20","key":"ebr240006r3","doi-asserted-by":"publisher","first-page":"12564","DOI":"10.3390\/ijms232012564","article-title":"Correlation between phenotype and genotype in CTNNB1 syndrome: a systematic review of the literature.","volume":"23","author":"Miro\u0161evic","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ebr240006r4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ajhg.2017.05.001","article-title":"Defects in the cell signaling mediator \u00df-catenin cause the retinal vascular condition FEVR.","volume":"100","author":"Panagiotou","year":"2017","journal-title":"Am J Hum Genetics"},{"issue":"12","key":"ebr240006r5","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s00417-023-06184-0","article-title":"Peripheral and central retinal vascular changes in asymptomatic family members of patients with familial exudative vitreoretinopathy.","volume":"261","author":"Ozdek","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"ebr240006r6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ophtha.2013.08.010","article-title":"High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy.","volume":"121","author":"Kashani","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"ebr240006r7","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.ophtha.2011.06.020","article-title":"Clinical presentation of familial exudative vitreoretinopathy.","volume":"118","author":"Ranchod","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"ebr240006r8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.64.2.18","article-title":"Familial exudative vitreoretinopathy and systemic abnormalities in patients with CTNNB1 mutations.","volume":"64","author":"Huang","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ebr240006r9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jmedgenet-2021-108259","article-title":"Novel truncating variants in CTNNB1 cause familial exudative vitreoretinopathy.","volume":"60","author":"He","year":"2023","journal-title":"J Med Genetics"},{"issue":"4","key":"ebr240006r10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/13816810.2015.1120318","article-title":"CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype.","volume":"37","author":"Dixon","year":"2016","journal-title":"Ophthalmic Genetics"},{"issue":"3","key":"ebr240006r11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/ICB.0000000000000990","article-title":"CTNNB1 (\u00df-catenin) vitreoretinopathy: imaging characteristics and surgical management.","volume":"16","author":"Tipsuriyaporn","year":"2022","journal-title":"Retinal Cases Brief Rep"},{"issue":"1","key":"ebr240006r12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"ebr240006r13","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1542","article-title":"Missense variants in CTNNB1 can be associated with vitreoretinopathy-seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype.","volume":"9","author":"Rossetti","year":"2021","journal-title":"Mol Genetics Genomic Med"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2822244\/jamaophthalmology_bedoukian_2024_br_240006_1726689733.65226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:24:50Z","timestamp":1726763090000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2822244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2847","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}